Format

Send to

Choose Destination
Arch Ophthalmol. 2012 Dec;130(12):1612-3. doi: 10.1001/archophthalmol.2012.1652.

Use of autologous serum eyedrops for the treatment of ocular surface disease: first US experience in a large population as an insurance-covered benefit.

[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Silverchair Information Systems
Loading ...
Support Center